The vision
The vision of Nanosep AB is that within the following year the technology will be an important tool for analytical chemistry in the pharmaceutical and biotech industries. The market for HPLC, the dominating analytical technique today, is 3225 million USD.
During the following 3 years focus is on sales within the separation community via the web-site for proof of market, finding a commercial partner that can take the technology and products to customers globally. The revenue stream of Nanosep will come from three main sources:
1) selling particles
2) licensing
3) implementation of consultancy services.
Nanosep has a strong know how platform to grow from. During 2010 Nanosep will be cash flow positive on a monthly basis. Furthermore the company will continue to grow its IP portfolio.